The Transition from Viral to Autoimmune Myocarditis

References

• Feldman A. M., McNamara D., Myocarditis N. Engl. J. Med. 2000; 343: 1388–1398
   PubMed Web of Science ®Google Scholar
• Aretz H. T., Billingham M. E., Edwards W. D., et al. Myocarditis: a histopathologic definition and classification. Am. J. Cardiovasc. Pathol. 1987; 1: 3–14
   PubMedGoogle Scholar
• Mason J. W., O'Connell J. B., Herskowitz A., Rose N. R., McManus B. M., Billingham M. E., Moon T. E., The Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N. Engl. J. Med. 1995; 333: 269–275
   PubMed Web of Science ®Google Scholar
• Rose N. R., Baughman K. L. Immune-Mediated Cardiovascular Disease. The Autoimmune Diseases, 3rd ed, N R Rose, I R Mackay, 1998; 623–636
   Google Scholar
• Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999; 99: 1091–1100
   PubMed Web of Science ®Google Scholar
• Caforio A. L. P., Goldman J. H., Baig M. K., et al. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart 1997; 77: 62–67
   PubMed Web of Science ®Google Scholar
• Schultheiss H. P., Bolte H. P. Immunological analysis of auto-antibodies against nucleotide translocator in dilated cardiomyopathy. J. Mol. Cell. Cardiol. 1985; 17: 603
   PubMed Web of Science ®Google Scholar
• Maisch B., Tostel-Soeder R., Stechemesser E., Berg P. A., Koch K. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin. Exp. Immunol. 1982; 48: 533
   PubMed Web of Science ®Google Scholar
• Grist N. R., Bell E. J. A six-year study of Coxsackievirus B infections in heart disease. J. Hyg. (London) 1974; 73: 165–172
   PubMedGoogle Scholar
• Woodruff J. F. Viral myocarditis. A review. Am. J. Pathol. 1980; 101: 427
   Web of Science ®Google Scholar
• Wolfgram L. J., Beisel K. W., Herskowitz A., Rose N. R. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. J. Immunol. 1986; 136: 1846–1852
   PubMed Web of Science ®Google Scholar
• Pummerer C., Berger P., Fruhwirfh M., Offner C., Neu N. Cellular infiltrate, major histocompatibility antigen expression and immunopathogenic mechanisms in cardiac myosin-induced myocarditis. Lab. Invest. 1991; 65: 538–547
   PubMed Web of Science ®Google Scholar
• Anderson D. R., Wilson J. E., Carthy C. M., Yang D., Kandolf R., McManus B. M. Direct interactions of Coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J. Virol. 1996; 70: 4632–4645
   PubMed Web of Science ®Google Scholar
• Huber S. A., Gauntt C. J., Sakkinen P. Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv. Virus Res. 1999; 51: 35–80
   Web of Science ®Google Scholar
• Huber S. A. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Lab. Invest. 1997; 76: 691–701
   PubMed Web of Science ®Google Scholar
• Finkel M. S., Oddis C. V., Jacob T. D., Watkins S. C., Hattler B. G., Simmons R. L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387–389
   PubMed Web of Science ®Google Scholar
• Oddis C. V., Finkel M. S. Cytokine-stimulated nitrate oxide production inhibits mitochondrial activity in cardiac myocytes. Biochem. Biophys. Res. Comm. 1995; 213: 1002–1009
   PubMed Web of Science ®Google Scholar
• Lowenstein C. J., Hill S. L., Lafond-Walker A., Wu J., Allen G., Landavere M., et al. ). J. Clin. Invest. 1996; 97: 1837–1843
   PubMed Web of Science ®Google Scholar
• Singh V. K., Mehrotra S., Narayan P., Pandey C. M., Agarwal S. S. Modulation of autoimmune diseases by nitric oxide. Immunol. Res. 2000; 22/1: 1–19
   Web of Science ®Google Scholar
• Hashimoto I., Iatsumi M., Nakagana M. The role of T lymphocytes in the pathogenesis of Coxsackievirus B3 heart disease. Br. J. Exp. Pathol. 1983; 64: 497–504
   PubMedGoogle Scholar
• Bachmaier K., Neu N., Pummerer C., Duncan G. S., Mak T. W., Marsuyama T., et al. I-NOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 1997; 96: 585–591
   PubMed Web of Science ®Google Scholar
• Ishiyama S., Hiroe M., Nishikawa T. M., Abe S., Shimojo T., Ito H., et al. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation 1997; 95: 489–496
   PubMed Web of Science ®Google Scholar
• Shin T., Kim S., Moon C., Wie M., Kim H. Aminoguanidine-induced amelioration of autoimmune encephalomyelitis is mediated by reduced expression of inducible nitric oxide synthase in the spinal cord. Immunol. Invest. 2000; 29: 233–241
   PubMed Web of Science ®Google Scholar
• Hirono S., Islan O., Nakazawa M., Yoshida Y., Kodama M., Shibata A., et al. Expression of rat inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics. Circ. Res. 1997; 80: 11–20
   PubMed Web of Science ®Google Scholar
• Mikami S., Kawashima S., Kanazawa K., Hirata K. I., Karayama Y., Hotta H., et al. Expression of nitric oxide synthase in a murine model of viral myocarditis induced by Coxsackievirus B3. Biochem. Biophys. Res. Comm. 1996; 220: 983–989
   PubMed Web of Science ®Google Scholar
• Kooy N. W., Lewis S. J., Royall J. A., Ye Y. Z., Kelly D. R., Beckman J. S. Extensive tyrosine nitration in human myocardial inflammation: presence of peroxynitrite. Critical Card. Med. 1997; 25: 812–819
   PubMed Web of Science ®Google Scholar
• Okura Y., Yamamoto T., Goto S., Inomata T., Hirono S., Hanawa H., et al. Characterization of cytokine and I-NOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J. Mol. Cell. Cardiol. 1997; 29: 491–502
   PubMed Web of Science ®Google Scholar
• Fields M., Lewis C. G., Lure M. D., Burns W. A., Anthoune W. E. Low dietary iron prevents free radical formation and heart pathology of copper-deficient rats fed fructose. Proc. Soc. Exp. Biol. Med. 1993; 202: 225–232
   PubMed Web of Science ®Google Scholar
• Ferdinandy P., Danial H., Ambrus I., Rothery R. A., Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ. Res. 2000; 87: 241–247
   PubMed Web of Science ®Google Scholar
• Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 1993; 329: 2002–2012
   PubMed Web of Science ®Google Scholar
• Horwitz M. S., La Cava A., Fine C., Rodriguez E., Ilic A., Sarvetnick N. Pancreatic expression of interferon-γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat. Med. 2000; 6: 693–697
   PubMed Web of Science ®Google Scholar
• Muller V., Steinhoff U., Reis L. F. L., Hemmi S., Pavlovic J., Zinkernagel R. M., et al. Functional role of type I and type II interferons in antiviral defense. Science 1994; 264: 1918–1921
   PubMed Web of Science ®Google Scholar
• Smith S. C., Allen P. M. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ. Res. 1992; 70: 856–863
   PubMed Web of Science ®Google Scholar
• Afonosyeva M., Wang Y., Koyza Z., Park S., Zilliox M. I., Schofield B. H., Hill S. L., Rose N. R. Experimental Autoimmune Myocarditis in A/J Mice is an Interleukin-4-Dependent Disease with a Th2 Phenotype. Am. J. Pathology 2001; 159: 193–203
   PubMed Web of Science ®Google Scholar
• Eriksson U., Kurrer M. O., Bingisser R., Eugster H. P., Saremaslani P., Follath R., et al. Lethal autoimmune myocarditis in interferon-7 receptor-deficient mice. Enhanced disease severity by impaired inducible nitric oxide synthase induction. Circulation 2001; 103: 18–21
   PubMed Web of Science ®Google Scholar
• Orange J. S., Biron C. A. Characterization of early IL-12 IFN-αβ and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 1996; 156: 4746–4756
   PubMed Web of Science ®Google Scholar
• Okura Y., Takeda K., Honda S., Hanawa H., Watanabe H., Kodama M., et al. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 help T-cells in rats. Circ. Res. 1998; 82: 1035–1042
   PubMed Web of Science ®Google Scholar